DDetect stomach cancerDetectCancer.org

Gastroscopy, biopsy and H. pylori risk

Stomach cancer detection depends on upper endoscopy when symptoms or risk justify it.

There is no broad average-risk screening program in many low-incidence countries, but high-incidence countries use upper endoscopic or radiographic programs. Alarm symptoms need diagnosis.

Screening realitySymptoms not to ignoreImmunotherapy
Educational, not personal medical advice. Unexplained weight loss, progressive swallowing trouble, vomiting, black stools, iron-deficiency anemia, persistent upper abdominal pain or early fullness needs medical assessment.
Gastroscopy

with biopsy is the key diagnostic test.

H. pylori

is a major modifiable risk factor.

Japan/Korea

have organized screening because incidence is higher.

Genes

CDH1 hereditary diffuse gastric cancer changes prevention and surveillance.

Brief outline

Most stomach cancers are gastric adenocarcinomas.

Cancer can arise from chronic inflammation, atrophic gastritis, intestinal metaplasia, dysplasia or hereditary pathways. Diffuse-type cancers can infiltrate subtly and may be harder to see.

Upper GI gastroscopy mucosa image.
Gastroscopy sees and samples suspicious upper GI lesions.

Detection frame

The detection question is whether symptoms are alarm features, whether H. pylori or premalignant stomach changes are present, and whether the patient comes from a high-incidence or inherited-risk group.

Do not ignore

Alarm symptoms should not be treated as simple indigestion.

Weight lossUnexplained weight loss with dyspepsia or early satiety is concerning.
Iron-deficiency anemiaCan reflect chronic bleeding from gastric cancer.
Black stools or vomiting bloodNeeds urgent evaluation.
Progressive dysphagiaCan occur with cardia/GE junction cancers.
Persistent vomitingCan reflect outlet obstruction.
Early satietyFeeling full quickly can occur with infiltrating or obstructing disease.

Risk and genetics

H. pylori and inherited risk matter.

H. pyloriChronic infection is a major risk factor; test-and-treat reduces risk in appropriate settings.
Atrophic gastritis/metaplasiaPremalignant changes can require endoscopic surveillance depending on extent and local guidance.
Diet and smokingHigh-salt/smoked foods and smoking increase risk.
Family historyEspecially diffuse gastric cancer or multiple relatives.
CDH1Hereditary diffuse gastric cancer can lead to prophylactic gastrectomy discussions.
Lynch and other syndromesMay affect endoscopic surveillance in selected families.

Screening

Screening depends strongly on country and risk.

Japan and South Korea screen because gastric cancer is common enough for population programs. In many lower-incidence countries, gastroscopy is symptom-driven or risk-driven rather than routine for everyone.

Diagnostic

Gastroscopy / upper GI endoscopy

Best route to see the stomach directly when alarm symptoms or suspicious imaging are present.

Tissue

Biopsy and histology

Confirms adenocarcinoma, lymphoma, GIST or benign disease.

Risk reduction

H. pylori testing

Breath, stool antigen, serology or biopsy-based tests; treatment matters.

Staging

CT chest/abdomen/pelvis

Assesses spread and operability.

Selected

Endoscopic ultrasound (EUS)

Can help local T/N staging in selected early or junctional tumors.

Selected

Staging laparoscopy

May find peritoneal spread missed on CT.

Images, labs and tissue

Gastroscopy plus biopsy is central.

Gastroscopy, also called upper GI endoscopy, allows direct inspection of the stomach, targeted biopsies and mapping of suspicious mucosa. The same examination may extend through the pylorus into the duodenum as gastroduodenoscopy/duodenoscopy. CT, EUS and laparoscopy may stage confirmed cancer.

Upper GI gastroscopy mucosa image.
Gastroscopy sees and samples suspicious stomach or upper GI lesions.
Upper GI endoscopy image.
Biopsy confirms what imaging suggests; this shows the upper GI route of detection rather than a cancer diagnosis.
Abdominal MRI example.
Cross-sectional imaging helps stage confirmed gastric cancer and evaluate spread.

Pros, cons and controversy

The controversy is geography and overuse.

In high-incidence countries, screening can find early gastric cancer that is curable endoscopically or surgically. In low-incidence countries, routine gastroscopy for everyone would create cost, sedation risk and many benign findings.

Stomach detection trials ImmunotherapyForStomachCancer.com TheTreatments.com TheCancers.com

Sources and trials

Good starting points.

NCI stomach cancerOverview and diagnostic context. NCI stomach screening PDQEvidence for screening in different populations. ClinicalTrials.gov stomach detectionScreening and diagnostic trials.